Blood platelets play an essential role in hemostasis, as well as in the pathophysiology of thrombosis. The purpose of this proposal is to investigate the cytoskeletal mechanics of platelet formation. Although it is well established that platelets originate from megakaryocytes, many unanswered questions remain regarding the mechanics by which platelets are formed and released. The favored model of platelet formation recognizes that terminally differentiated megakaryocytes extend long cytoplasmic processes, designated proplatelets that function as essential intermediate structures in platelet biogenesis. We have used a mouse megakaryocyte culture system that produces bonafide platelets to study the process of platelet biogenesis. Platelet formation begins with the extension of large pseudopodia from the megakaryocyte surface. Cortical bundles of microtubules are used to elongate these processes into proplatelets, which ultimately form prominent coils of microtubules at their bulbous ends. The linear arrays of microtubules that line proplatelets also serve as tracks for the transport of organelles and granules into assembling platelets. The importance of actin filaments in platelet formation is demonstrated by their essential role in the amplification of proplatelets and by the thrombocytopenia and abnormal morphology of platelets lacking particular actin associated proteins. Although our understanding of platelet production is improving, little is known of the molecular mechanisms by which the cytoskeleton contributes to platelet formation and release. To address this question, a research plan of three specific aims is proposed.
Aim 1 will test the hypothesis that microtubule sliding powers proplatelet elongation in living megakaryocytes. The contribution of the molecular motor cytoplasmic dynein will be established using knock-down and dominant-negative strategies and the ultrastructure of the proplatelet microtubule array, including microtubule numbers, length, and polarity will be resolved using electron microscopy.
In Aim 2, we will define the mechanisms by which individual platelets are released from proplatelets during the final step of platelet formation. These experiments will address the cytoskeletal forces that power the final release step. In the last Aim, we will examine the role of the actin binding protein Filamin A in platelet formation using Filamin A knockout mice. We will establish when the essential Filamin A-von Willebrand factor receptor connection is made during platelet production using immunoelectron microscopy. The regulation of platelet production and function are crucial determinants of cardiovascular health. It is anticipated that the knowledge gained by successful completion of the proposed work will provide us with a better understanding of the mechanics of platelet formation and suggest strategies for treatment of patients with disorders of hemostasis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL068130-10
Application #
8015560
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Sarkar, Rita
Project Start
2001-07-01
Project End
2011-12-31
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
10
Fiscal Year
2011
Total Cost
$376,280
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Noetzli, Leila J; Italiano Jr, Joseph E (2018) Unlocking the Molecular Secrete(s) of ?-Granule Biogenesis. Arterioscler Thromb Vasc Biol 38:2539-2541
Paul, David S; Casari, Caterina; Wu, Congying et al. (2017) Deletion of the Arp2/3 complex in megakaryocytes leads to microthrombocytopenia in mice. Blood Adv 1:1398-1408
Machlus, Kellie R; Wu, Stephen K; Vijey, Prakrith et al. (2017) Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis. Blood 130:1132-1143
Kim, Kyungho; Tseng, Alan; Barazia, Andrew et al. (2017) DREAM plays an important role in platelet activation and thrombogenesis. Blood 129:209-225
Cunin, Pierre; Penke, Loka R; Thon, Jonathan N et al. (2017) Megakaryocytes compensate for Kit insufficiency in murine arthritis. J Clin Invest 127:1714-1724
Johnson, Kelly E; Forward, Jodi A; Tippy, Mason D et al. (2017) Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis. Arterioscler Thromb Vasc Biol 37:664-674
Zufferey, Anne; Speck, Edwin R; Machlus, Kellie R et al. (2017) Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets. Blood Adv 1:1773-1785
Machlus, Kellie R; Johnson, Kelly E; Kulenthirarajan, Rajesh et al. (2016) CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood 127:921-6
Machlus, Kellie R; Wu, Stephen K; Stumpo, Deborah J et al. (2016) Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation. Blood 127:1468-80
Bender, Markus; Thon, Jonathan N; Ehrlicher, Allen J et al. (2015) Microtubule sliding drives proplatelet elongation and is dependent on cytoplasmic dynein. Blood 125:860-8

Showing the most recent 10 out of 55 publications